Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Substance-Related Disorders D019966 2 associated lipids
Hepatitis D006505 11 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Harris J et al. Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. 2000 Neuroreport pmid:10976969
Levin M and Mercola M Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. 2000 Dev. Dyn. pmid:10974676
Bannerman P et al. Early migratory rat neural crest cells express functional gap junctions: evidence that neural crest cell survival requires gap junction function. 2000 J. Neurosci. Res. pmid:10972957
Van den Bossche I and Vanheel B Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. 2000 Br. J. Pharmacol. pmid:10960073
Martin BR et al. Cannabinoid properties of methylfluorophosphonate analogs. 2000 J. Pharmacol. Exp. Ther. pmid:10945879
Okamoto H et al. Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. 2000 Thromb. Res. pmid:10942792
Salzet M et al. Comparative biology of the endocannabinoid system possible role in the immune response. 2000 Eur. J. Biochem. pmid:10931174
Spicuzza L et al. Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves. 2000 Br. J. Pharmacol. pmid:10928980
Maccarrone M et al. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. 2000 J. Biol. Chem. pmid:10913156
Palmer SL et al. Natural and synthetic endocannabinoids and their structure-activity relationships. 2000 Curr. Pharm. Des. pmid:10903399
Di Marzo T et al. Endocannabinoids: new targets for drug development. 2000 Curr. Pharm. Des. pmid:10903398
Hansen HH et al. Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. 2000 J. Neurochem. pmid:10899965
Szöke E et al. Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones. 2000 Neuroreport pmid:10884049
Fichera M et al. A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. 2000 J. Med. Chem. pmid:10882356
Di Marzo V et al. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. 2000 FASEB J. pmid:10877836
Andersson M et al. Neurotoxicity of glutamate in chick telencephalon neurons: reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide. 2000 Arch. Toxicol. pmid:10877002
Tytgat J et al. Cannabinoid mimics in chocolate utilized as an argument in court. 2000 Int. J. Legal Med. pmid:10876983
Song ZH and Zhong M CB1 cannabinoid receptor-mediated cell migration. 2000 J. Pharmacol. Exp. Ther. pmid:10871313
Hillard CJ Endocannabinoids and vascular function. 2000 J. Pharmacol. Exp. Ther. pmid:10871291
Hohmann AG and Herkenham M Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. 2000 Synapse pmid:10842353
Piomelli D et al. The endocannabinoid system as a target for therapeutic drugs. 2000 Trends Pharmacol. Sci. pmid:10838609
Szolcsányi J Anandamide and the question of its functional role for activation of capsaicin receptors. 2000 Trends Pharmacol. Sci. pmid:10838604
Zygmunt PM et al. Differential actions of anandamide, potassium ions and endothelium-derived hyperpolarizing factor in guinea-pig basilar artery. 2000 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10832608
Zygmunt PM et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. 2000 Eur. J. Pharmacol. pmid:10822052
Davis JB et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. 2000 Nature pmid:10821274
Jarrahian A et al. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. 2000 J. Neurochem. pmid:10820223
Beltramo M and Piomelli D Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. 2000 Neuroreport pmid:10817598
Boger DL et al. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10805767
Costa B et al. Precipitated and spontaneous withdrawal in rats tolerant to anandamide. 2000 Psychopharmacology (Berl.) pmid:10805606
Yagen B and Burstein S Novel and sensitive method for the detection of anandamide by the use of its dansyl derivative. 2000 J. Chromatogr. B Biomed. Sci. Appl. pmid:10798298
Maccarrone M et al. Anandamide uptake by human endothelial cells and its regulation by nitric oxide. 2000 J. Biol. Chem. pmid:10788462
Hungund BL and Basavarajappa BS Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence. 2000 Mar-Apr Alcohol Alcohol. pmid:10787386
Kunos G et al. Cardiovascular effects of endocannabinoids--the plot thickens. 2000 Prostaglandins Other Lipid Mediat. pmid:10785543
Di Marzo V et al. Cannabimimetic fatty acid derivatives in cancer and inflammation. 2000 Prostaglandins Other Lipid Mediat. pmid:10785541
Burstein SH et al. Oxidative metabolism of anandamide. 2000 Prostaglandins Other Lipid Mediat. pmid:10785540
Hillard CJ Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. 2000 Prostaglandins Other Lipid Mediat. pmid:10785538
Sarker KP et al. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. 2000 FEBS Lett. pmid:10781801
Costa B and Colleoni M Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinol. 2000 Eur. J. Pharmacol. pmid:10781666
Castellano C et al. Strain-dependent effects of anandamide on memory consolidation in mice are antagonized by naltrexone. 1999 Behav Pharmacol pmid:10780251
Gonsiorek W et al. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. 2000 Mol. Pharmacol. pmid:10779390
Beltramo M et al. Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. 2000 J. Neurosci. pmid:10777802
Maccarrone M et al. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. 2000 Lancet pmid:10776746
Lockwood CJ Prediction of pregnancy loss. 2000 Lancet pmid:10776739
Hao S et al. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. 2000 Eur. J. Pharmacol. pmid:10762668
Braud S et al. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. 2000 FEBS Lett. pmid:10760504
Brăiloiu C et al. [Endothelium-derived hyperpolarizing factor]. 1998 Jul-Dec Rev Med Chir Soc Med Nat Iasi pmid:10756843
Gómez del Pulgar T et al. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. 2000 Biochem. J. pmid:10749665
Rajan S et al. TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An extracellular histiding as pH sensor. 2000 J. Biol. Chem. pmid:10747866
Markey SP et al. Base- and acid-catalyzed interconversions of O-acyl- and N-acyl-ethanolamines: a cautionary note for lipid analyses. 2000 J. Lipid Res. pmid:10744787
Smart D and Jerman JC Anandamide: an endogenous activator of the vanilloid receptor. 2000 Trends Pharmacol. Sci. pmid:10740287
Di Marzo V et al. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. 2000 J. Neurochem. pmid:10737621
Wang Y et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. 2000 FEBS Lett. pmid:10734225
Muthian S et al. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier. 2000 J. Pharmacol. Exp. Ther. pmid:10734181
González S et al. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. 2000 Biochem. Biophys. Res. Commun. pmid:10733937
Lay L et al. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. 2000 Eur. J. Pharmacol. pmid:10720647
Oliveira L et al. Effects of some isoprostanes on the human umbilical artery in vitro. 2000 Br. J. Pharmacol. pmid:10711349
Houser SJ et al. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. 2000 Brain Res. pmid:10700588
Arai Y et al. Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. 2000 Biomed. Chromatogr. pmid:10694706
Smart D et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). 2000 Br. J. Pharmacol. pmid:10694225
Maccarrone M et al. Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. 2000 FEBS Lett. pmid:10692582
Lagalwar S et al. Anandamides inhibit binding to the muscarinic acetylcholine receptor. 1999 Aug-Oct J. Mol. Neurosci. pmid:10691292
Rakhshan F et al. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. 2000 J. Pharmacol. Exp. Ther. pmid:10688610
Griffin G et al. Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor. 2000 J. Pharmacol. Exp. Ther. pmid:10688601
Tiger G et al. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. 2000 Biochem. Pharmacol. pmid:10677581
Schmid PC et al. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. 2000 Chem. Phys. Lipids pmid:10669310
Zygmunt PM et al. Anandamide - the other side of the coin. 2000 Trends Pharmacol. Sci. pmid:10664604
Sinor AD et al. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. 2000 Neurosci. Lett. pmid:10653017
Sugiura T et al. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. 2000 J. Biol. Chem. pmid:10617657
Melck D et al. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. 2000 Endocrinology pmid:10614630
Melck D et al. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. 1999 FEBS Lett. pmid:10606728
Bisogno T et al. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. 1999 Arch. Biochem. Biophys. pmid:10577359
Járai Z et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10570211
Gifford AN et al. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). 1999 Eur. J. Pharmacol. pmid:10556675
Akinshola BE et al. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. 1999 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10543424
Yousif MH and Oriowo MA Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. 1999 Pharmacol. Res. pmid:10527656
McAllister SD et al. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. 1999 J. Pharmacol. Exp. Ther. pmid:10525080
Chaytor AT et al. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. 1999 J. Physiol. (Lond.) pmid:10523421
Katayama K et al. Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme. 1999 Biochim. Biophys. Acta pmid:10521704
Walker JM et al. Pain modulation by release of the endogenous cannabinoid anandamide. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518599
Wiley JL Cannabis: discrimination of "internal bliss"? 1999 Pharmacol. Biochem. Behav. pmid:10515300
Kuwae T et al. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. 1999 FEBS Lett. pmid:10508930
Leweke FM et al. Elevated endogenous cannabinoids in schizophrenia. 1999 Neuroreport pmid:10501554
Molderings GJ et al. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. 1999 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10494885
Di Marzo V et al. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. 1999 Curr. Med. Chem. pmid:10469888
Di Marzo V Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. 1999 Life Sci. pmid:10462065
Howlett AC et al. Signal transduction of eicosanoid CB1 receptor ligands. 1999 Life Sci. pmid:10462062
Khanolkar AD and Makriyannis A Structure-activity relationships of anandamide, an endogenous cannabinoid ligand. 1999 Life Sci. pmid:10462061
Martin BR et al. Discovery and characterization of endogenous cannabinoids. 1999 Life Sci. pmid:10462059
Melck D et al. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. 1999 Biochem. Biophys. Res. Commun. pmid:10448105
González S et al. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. 1999 Life Sci. pmid:10447218
Zygmunt PM et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. 1999 Nature pmid:10440374
Ueda N et al. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. 1999 FEBS Lett. pmid:10431820
Hansen HS et al. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. 1999 Lipids pmid:10419193
Di Marzo V et al. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. 1999 Lipids pmid:10419192
Zenor BN et al. Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves. 1999 Life Sci. pmid:10416818
De Petrocellis L et al. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. 1999 Neuroscience pmid:10392859
Ameri A et al. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. 1999 Br. J. Pharmacol. pmid:10372827
Gebremedhin D et al. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. 1999 Am. J. Physiol. pmid:10362691
Ng EW et al. Unique analogues of anandamide: arachidonyl ethers and carbamates and norarachidonyl carbamates and ureas. 1999 J. Med. Chem. pmid:10354405
Fimiani C et al. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. 1999 Cell. Signal. pmid:10353693